Dr. Victoria Elizabeth Wang, MD, PhD

Dr. Wang practices at Surgery Center Palo Alto in Palo Alto, California.

Dr. Wang's NPI, 1629264098, was assigned on September 19, 2007. Dr. Wang graduated from Harvard Medical School in 2006. Dr. Wang holds California license A116118.

Dr. Wang's primary practice is Surgery Center Palo Alto, at 795 El Camino Real, Palo Alto, CA 94301. The practice phone is (650) 324-1832.

Dr. Wang's primary practice is Surgery Center Palo Alto in Palo Alto, California. Dr. Wang is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Wang to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wang is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Wang's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists lung cancer among the conditions Dr. Wang treats.

CMS data shows 305 Medicare services from Dr. Wang across 3 procedure codes in 2024, for 145 Medicare patients. Medicare paid $25,245 for them.

CMS counts 145 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 58 patients. 68% of them have high cholesterol, and 59% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 56, with 55% women.

In 2024, Dr. Wang wrote 153 Medicare Part D claims for 67 patients. 71% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $223,965 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 37 papers to Dr. Wang, published from 2004 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Lung Neoplasms, Breast Neoplasms and Carcinoma, Non-Small-Cell Lung. Dr. Wang has published most often in JCO Precis Oncol. Dr. Wang's most frequent co-authors are Carlos L. Arteaga, MD, Alice Chen, DO and Robert Gray, MD.

Dmand AI links Dr. Wang to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute and Leukemia, Myeloid.

CMS Open Payments shows 9 general payments to Dr. Wang from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 92% of the total. Daiichi Sankyo Inc. paid the most, $650.

Dr. Wang graduated from Harvard Medical School in 2006.

Dr. Wang is in network with 10 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.